More than 200 students from across Hampshire attended a STEM event at the National Oceanography Centre. Held on Wednesday, ...

Biopure is falling more than 14 percent to $2.60 after the company filed a prospectus supplement under its shelf registration statement for the sale of up to 5.5 million class A common shares at a ...

Biopure also issued warrants to these investors, enabling them to buy 20 million shares of common stock at an exercise price of 31 cents a share.

Biopure said it had $6.6 million in cash at the end of October, which, combined with its stock offering, should be enough to fund the company through August 2007.

Biopure also reported that it lost $9.4 million, or 16 cents a share, on revenue of $1.77 million for the three months ended Oct. 31, the fourth quarter of its last fiscal year. This compares with ...

Howard Richman better hope there's no such thing as karma. The former BioPure vice president was sentenced last month to three years in prison for faking cancer to avoid an SEC investigation.

The event aimed to inspire young people about STEM career paths and to raise aspirations. Read more Pupils inspired by different careers at annual event held at secondary school ...

The former chief executive of Biopure has agreed to pay a $120,000 civil penalty to settle allegations of misleading public statements about efforts to gain regulatory approval of the company's ...

Biopure Corp., a Cambridge company that’s been reduced over the past year to a shell of assets and unrealized biotech potential, has gone belly up. The 25-year-old firm, known for its synthetic ...

A former Biopure Corp. executive agreed to pay a $150,000 civil penalty to settle allegations that he misled investors about the Massachusetts biotech company's prospects for obtaining regulatory ...